πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6476201

Methods for the production of non-covalently complexed and multivalent proteosome sub-unit

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6475741

Neutrophil chemotactic factor cloned cDNA and monoclonal antibodies thereto

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6475527

Use of chlorate ion or preparations thereof for reduction of food borne pathogens

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 05 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6472438

Active topical skin protectants containing S-330

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6472437

Active topical skin protectants

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6469049

Method of treating, preventing or inhibiting central nervous system injuries and diseases

The United States of America as represented by the Secretary of the Army Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6468983

RNase L activators and antisense oligonucleotides effective to treat telomerase-expressing

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6468524

AAV4 vector and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 22 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6458590

Methods and compositions for treatment of restenosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6455509

Dengue nucleic acid vaccines that induce neutralizing antibodies

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Sep 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451763

Retinal pigmented epithelium derived neurotrophic factor and methods of use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451338

Liposomes containing particulate materials

The Secretary of State for Defence in Her Britannic Majest's Government of the United Kingdom of Great Britain and Northern Ireland Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6451309

Prophylactic and therapeutic monoclonal antibodies

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 17 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6448245

Methods of and compounds for inhibiting calpains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6447796

Sustained release hydrophobic bioactive PLGA microspheres

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 10 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6444445

Live vaccine against Brucellosis

The United States of America as represented by the Secretary of the Army Β· Granted Tue Sep 03 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 29 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6441156

Calcium channel compositions and methods of use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 27 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6437005

Active topical skin protectants using polymer coated metal alloys

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 20 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6433023

Compositions having anti-leishmanial activity

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6432434

Treatment of and/or prophylaxis against brain and spinal cord injury

The United States of America as represented by the Secretary of the Army Β· Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6432408

Swine hepatitis E virus and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 13 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6429232

Method of treating atherosclerosis or restenosis using microtubule stabilizing agent

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 06 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6428790

Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 06 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6426198

Genes for Niemann-Pick type C disease

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired